Search

everythinglearnresearchcommunity

for

Search:↓

People with skin conditions like psoriasis and eczema have higher anxiety levels.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Patients with chronic skin disorders often experience depression, anxiety, and reduced quality of life and may benefit from psychiatric help.

Excessive body hair in women with PCOS can lower self-esteem and cause depression and anxiety.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Coping skills in PCOS patients don't significantly affect mental health, quality of life, or body weight.

Women with hair loss often feel depressed, while men are more anxious and aggressive.

Some psychiatric medications can cause hair loss, but stopping or reducing the dose usually reverses it.

MS treatments can cause significant hair loss, affecting mental health.

Two sisters with lipoedematous scalp suggest a genetic influence in the condition.

Valproic acid can rarely cause reversible nail discoloration.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Endogenous neurosteroids may set a baseline mood.

A girl with red hair developed hair-pulling and body image disorders after being bullied for her hair color.

Facial hair loss and psychosocial issues are crucial in deciding treatment for alopecia areata.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Kids with vitiligo, psoriasis, or alopecia areata are more likely to experience anxiety, depression, and social challenges.

Nail issues are common in alopecia areata patients.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Psychodermatosis is reclassified based on brain-skin interaction, dividing conditions into psychogenic and psychosomatic categories.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.

An 8-year-old girl's eyebrow hair loss was linked to atomoxetine for ADHD but grew back after stopping the medication.

A 24-year-old man developed both alopecia areata universalis and type 1 diabetes at the same time, which is rare.